annual book value:
$48.05B+$366.77M(+0.77%)Summary
- As of today (April 19, 2025), TAK annual book value is $48.05 billion, with the most recent change of +$366.77 million (+0.77%) on March 31, 2024.
- During the last 3 years, TAK annual book value has risen by +$1.16 billion (+2.48%).
- TAK annual book value is now at all-time high.
Performance
TAK Book value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly book value:
$47.24B-$1.22B(-2.52%)Summary
- As of today (April 19, 2025), TAK quarterly book value is $47.24 billion, with the most recent change of -$1.22 billion (-2.52%) on December 1, 2024.
- Over the past year, TAK quarterly book value has dropped by -$1.22 billion (-2.52%).
- TAK quarterly book value is now -2.52% below its all-time high of $48.46 billion, reached on June 30, 2024.
Performance
TAK quarterly book value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Book value Formula
Book Value = Total Assets − Total Liabilities
TAK Book value Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.8% | -2.5% |
| 3 y3 years | +2.5% | -0.9% |
| 5 y5 years | +2.8% | +0.7% |
TAK Book value Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +3.2% | -2.5% | +2.1% |
| 5 y | 5-year | at high | +9.9% | -2.5% | +8.4% |
| alltime | all time | at high | +399.6% | -2.5% | +178.8% |
Takeda Pharmaceutical Company Limited Book value History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $47.24B(-2.5%) |
| Sep 2024 | - | $48.46B(-0.0%) |
| Jun 2024 | - | $48.46B(+0.8%) |
| Mar 2024 | $48.05B(+0.8%) | $48.05B(+0.5%) |
| Dec 2023 | - | $47.81B(+1.0%) |
| Sep 2023 | - | $47.33B(-1.0%) |
| Jun 2023 | - | $47.80B(+0.2%) |
| Mar 2023 | $47.69B(+2.4%) | $47.69B(+1.2%) |
| Dec 2022 | - | $47.10B(+1.4%) |
| Sep 2022 | - | $46.47B(+0.5%) |
| Jun 2022 | - | $46.25B(-0.7%) |
| Mar 2022 | $46.56B(-0.7%) | $46.56B(+0.5%) |
| Dec 2021 | - | $46.33B(-2.6%) |
| Sep 2021 | - | $47.56B(+0.4%) |
| Jun 2021 | - | $47.39B(+1.0%) |
| Mar 2021 | $46.89B(+7.3%) | $46.89B(+4.3%) |
| Dec 2020 | - | $44.94B(+1.9%) |
| Sep 2020 | - | $44.12B(+1.3%) |
| Jun 2020 | - | $43.56B(-0.3%) |
| Mar 2020 | $43.71B(-6.5%) | $43.71B(-2.3%) |
| Dec 2019 | - | $44.74B(-0.7%) |
| Sep 2019 | - | $45.07B(-0.1%) |
| Jun 2019 | - | $45.14B(-3.4%) |
| Mar 2019 | $46.74B(+148.7%) | $46.74B(+153.0%) |
| Dec 2018 | - | $18.47B(-3.1%) |
| Sep 2018 | - | $19.07B(+3.2%) |
| Jun 2018 | - | $18.49B(-1.6%) |
| Mar 2018 | $18.80B(+10.9%) | $18.80B(+0.2%) |
| Dec 2017 | - | $18.75B(+1.1%) |
| Sep 2017 | - | $18.54B(+3.1%) |
| Jun 2017 | - | $17.98B(+6.1%) |
| Mar 2017 | $16.94B(-2.3%) | $16.94B(-0.6%) |
| Dec 2016 | - | $17.04B(-5.2%) |
| Sep 2016 | - | $17.97B(+2.2%) |
| Jun 2016 | - | $17.59B(+1.5%) |
| Mar 2016 | $17.34B | $17.34B(-0.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | - | $17.42B(-1.5%) |
| Sep 2015 | - | $17.68B(+0.2%) |
| Jun 2015 | - | $17.65B(-0.9%) |
| Mar 2015 | $17.80B(-25.8%) | $17.80B(-15.0%) |
| Dec 2014 | - | $20.95B(-7.0%) |
| Sep 2014 | - | $22.52B(-4.4%) |
| Jun 2014 | - | $23.55B(-1.9%) |
| Mar 2014 | $24.01B(-0.6%) | $24.01B(+5.7%) |
| Dec 2013 | - | $22.71B(-2.6%) |
| Sep 2013 | - | $23.33B(+3.9%) |
| Jun 2013 | - | $22.46B(-7.0%) |
| Mar 2013 | $24.15B(-5.7%) | $24.15B(+0.7%) |
| Dec 2012 | - | $23.98B(-2.7%) |
| Sep 2012 | - | $24.64B(+3.4%) |
| Jun 2012 | - | $23.83B(-6.9%) |
| Mar 2012 | $25.60B(+1.8%) | $25.60B(+3.8%) |
| Dec 2011 | - | $24.67B(-4.7%) |
| Sep 2011 | - | $25.90B(+0.9%) |
| Jun 2011 | - | $25.66B(+2.1%) |
| Mar 2011 | $25.14B(+10.9%) | $25.14B(+0.1%) |
| Dec 2010 | - | $25.13B(+1.8%) |
| Sep 2010 | - | $24.68B(+7.0%) |
| Jun 2010 | - | $23.06B(+1.7%) |
| Mar 2010 | $22.68B(+11.6%) | $22.68B(+2.2%) |
| Dec 2009 | - | $22.18B(-2.5%) |
| Sep 2009 | - | $22.75B(+12.0%) |
| Mar 2009 | $20.32B(-11.0%) | $20.32B(-1.8%) |
| Dec 2008 | - | $20.68B |
| Mar 2008 | $22.83B(+11.2%) | - |
| Mar 2007 | $20.52B(+2.9%) | - |
| Mar 2006 | $19.94B(+6.8%) | - |
| Mar 2005 | $18.67B(+9.3%) | - |
| Mar 2004 | $17.09B(+28.6%) | - |
| Mar 2003 | $13.28B(+24.3%) | - |
| Mar 2002 | $10.68B(+11.1%) | - |
| Mar 2001 | $9.62B | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual book value?
- What is the all time high annual book value for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual book value year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly book value?
- What is the all time high quarterly book value for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly book value year-on-year change?
What is Takeda Pharmaceutical Company Limited annual book value?
The current annual book value of TAK is $48.05B
What is the all time high annual book value for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual book value is $48.05B
What is Takeda Pharmaceutical Company Limited annual book value year-on-year change?
Over the past year, TAK annual book value has changed by +$366.77M (+0.77%)
What is Takeda Pharmaceutical Company Limited quarterly book value?
The current quarterly book value of TAK is $47.24B
What is the all time high quarterly book value for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly book value is $48.46B
What is Takeda Pharmaceutical Company Limited quarterly book value year-on-year change?
Over the past year, TAK quarterly book value has changed by -$1.22B (-2.52%)